interleukin 6) is a lymphokine with many biological activities.X) CDNAcloning has shown its primary structure,2) although several heterogeneous BSF-2 molecules with dissimilar N-termini have been reported in human cell lines.3'4) Moreover, it has been suggested that natural BSF-2 is glycosylated, 5'6) although the function of the glycosylation is not well understood; recombinant BSF-2 produced in E. colin) is non-glycosylated. BSF-2 production and purification. The recombinant BSF-2 was produced using 106 CHO cells/ml of alphaMEMand 106 NIH3T3 cells/ml ofDMEMmedium. The produced BSF-2 was purified with an affinity column of anti-BSF-2 monoclonal antibody10) directly from the culture medium, and further purified by RP-HPLC.
Recombinant BSF-2 and Ala-BSF-2 produced in E. coli. Ala-BSF-2 were prepared from E. coli protein fused with the human IL-2 N-terminus by kallikrein cleavage, as described previously.7) E. coli recombinant BSF-2 was further processed by aminopeptidase-P.
Detection of glycosylation. Saccharides were detected using lectins. One microgram of purified BSF-2 was electrophoresed into an SDS-polyacrylamide gel, westernAbbreviations: BSF-2, B cell stimulatory factor 2; GlcNAc, N-acetylglucosamine; DHFR, dihydrofolate reductase; MTX, methotrexate; RP-HPLC, reverse-phase HPLC; Con A, concanavalin A; LCA, lentil lectin; PHA-E4, phytohemagglutinin E4; PNA, peanut lectin; RCA120Ricinus communis lectin 120; WGA,wheat-germ lectin.
blotted onto a nitrocellulose filter, and treated with 6 types of peroxidase-linked lectin (Lectin-per. kit A, Seikagaku Kogyo Co., Ltd., Japan). The lectin beinging reaction was done under the conditions recommended in the instruction manual.
Search for exo-protease in the culture medium. One hundred micrograms of purified Ala-BSF-2 was added to 200 ml ofa culture of 106/ml CHOdhfr~cells, and cultured for 4 days. Then the BSF-2 was purified and its N-terminal sequence was analized.
Assay of BSF-2 productivity and specific activity. The BSF-2 was measured by ELISA (enzyme-linked immunosorbent assay) using mouse monoclonal and rabbit polyclonal anti-BSF-2 antibody.10) BSF-2 activity was assayed as the activity ofIgM production by SKW-C14.* x} N-Terminus sequencing. Six micrograms of purified BSF-2 was sequenced using an amino acid sequencer (Applier Biosystems Inc.).
Results
Production of CHOcells with high BSF-2 expression Gene amplification with the DHFRgene was used to obtain high BSF-2-expressing CHO cells. Transfectants requiring no nucleic acid were cultured in increasing concentrations of MTX.BSF-2 productivity increased in parallel with the increase in MTXconcentration (Fig.   1 ). The maximum BSF-2 productivity, 1700 ng/ml, was obtained when the cells were resistant to 10"5m MTX. The higher MTX concentration led to inhibition of cell growth, and a decrease of BSF-2 productivity.
Purification of recombinant BSF-2 Figure 2 shows SDS-PAGEof recombinant BSF-2 purified from CHO and NIH3T3. The purified BSF-2 gave a single peak in RP-HPLC. The recombinant BSF-2 formed a broad band at approximately 23kDa and an additional band at 31 kDa. The broad 23-kDa band was found to consist of several bands (less in BSF-2; data not shown). The proteins therefore seemed to be several closely related types of molecules.
Detection of saccharides of purified BSF-2
The main 23-kDa molecule of BSF-2 pro- (10) Val (3) Val (8) Gly (ll) Gly (6) NIH3T3
Val (16) Glu (3) Gly (5) Glu (3) Glu (9) Gly (1) Asp (
Lys (2) The numbers represent quantity of amino acid detected (pmol). The quantities of serine residues * were not calculated because they were not quantitatively recovered.
duced by NIH3T3 or CHO was glycosylated, because of its responsiveness to someof the lectins used (Table I) . Non-glycosylated E. coli BSF-2showed no responsiveness to any of the lectins. The form of the saccharide was suggested to have N-linked oligosaccharide(s) with a triantennary structure or bisecting GlcNAc, according to the binding pattern (binding to PHA-E4 and RCA120, but not to ConA). The binding of BSF-2 from CHOwas somewhat weaker than that ofNIH3T3 BSF-2.
N-Terminal heterogeneity
The N-terminal amino acids of purified BSF-2 detected are shown in Table II . The complex pattern indicates that these proteins have several closely related N-termini. All of these N-terminal amino acids were included in the sequence of BSF-2, Ala-Pro-Val-ProPro-Gly (Fig. 3) .
The composition of the BSF-2 species of each N-terminus in the mixture was not analized because of the proline-rich nature of the sequence; the peptide bonds after proline are not cleaved completely. However, the composition was suggested to differ between CHOand NIH3T3. The major N-terminal amino acid in CHO was Val or Gly, but in NIH3T3, it was Ala or Val. The fourth Pro was not detected in NIH3T3.
No protease activity in the culture medium for BSF-2 N-terminus processing was found; only alanine was detected at the N-terminus of E. coli Ala-BSF-2 in CHO cell culture (Materials and Methods).
Discussion
Wehave described here the characterization of recombinant BSF-2. First, a cell line expressing a high level of BSF-2 was produced. BSF-2 productivity in CHOtransfectants was increased in parallel with the MTXconcentration up to 1700ng/ml at 10"5m MTX. Further MTXaddition resulted in inhibition of cell growth. SDS-PAGE showed a 31-kDa BSF-2 molecule as well as the 23-kDa molecules observed in several previous studies.5 '6'12'13) This heterogeneity may be due to heterogeneous glycosylation5' 6) or phosphorylation. 13) It has been reported that the 26-30-KDa molecules were tunicamycin-sensitive, and are suggested to be N-glycosylated, but the 23-25-kDa molecules were not.5'6) However, we detected resposiveness of 23-25-kDa molecules to lectins, and a previous study also revealed uptake of labelled glycosamine by these molecules.5) The lectin binding pattern found in this study suggested N-glucosylation. In view of their degree of responsiveness to lectins, the saccharides of BSF-2 derived from CHOand NIH3T3 may differ. In fact, it has been reported that the saccharide moiety of recombinant beta interferon differs amongthe cells producing it.14)
The N-terminus of purified BSF-2 was hyper-heterogeneous.
Five or six molecular species were found in the purified BSF-2. Some of the N-termini have been reported previously;
included Ala-,3) a mixture of Ala-and Val-,4) or a Pro-Val-Pro-Pro-sequence.2) Three other species were found for the first time in this study.
No processing was observed in the E. coli Ala-BSF-2 in the CHO cell culture, so such heterogeneity was not created in the culture mecium. It may be created at some stage in the secretion process, due to processing by putative aminopeptidase (s) or differences in the cleavage site of the signal peptidase. No other examples of N-terminal heterogeneity in proteins produced by mammaliancells have been reported, although in yeast processing at the signal junction can be variable.15) The specific activity of the mixture of these recombinant BSF-2 molecules was 4100 U//ig, identical to that of natural or E. co/z-derived BSF-2, and thus no difference is apparent between the activities of glycosylated and non-glycosylated BSF-2 species.
